Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NALFD) is now a leading cause of chronic liver disease worldwide, in part as a consequence of rapidly rising levels of obesity and metabolic syndrome, and is a major risk factor for cirrhosis, hepatocellular carcinoma and liver-related mortality. NAFLD stems a my…